Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Agenus Inc
(NQ:
AGEN
)
5.280
+0.110 (+2.13%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Agenus Inc
< Previous
1
2
3
4
5
6
7
8
Next >
Illumina, Seagen And Other Big Stocks Moving Higher On Monday
March 13, 2023
U.S. stocks traded slightly lower, with the Nasdaq Composite dropping around 0.2% on Monday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Earnings Preview For Agenus
March 13, 2023
Via
Benzinga
Agenus Cancels Conference Call to Discuss the Company’s Minority Cash Holdings at SVB in Light of Government’s SVB Deposit Access Announcement
March 12, 2023
Conference Call Cancelled
From
Agenus Inc.
Via
GlobeNewswire
Agenus Schedules Conference Call to Discuss the Company’s Minority Cash Holdings at SVB
March 11, 2023
Conference Call on Monday, March 13, 2023 at 8:30 a.m. ET
From
Agenus Inc.
Via
GlobeNewswire
Looking Into Agenus's Return On Capital Employed
December 05, 2022
Via
Benzinga
Why Shares of Agenus Rose 12.5% on Friday
December 02, 2022
Agenus presented data this week on a combination therapy.
Via
The Motley Fool
Agenus to Provide Corporate Update and Fourth Quarter & Full Year 2022 Financial Report
February 28, 2023
Conference Call on Tuesday, March 14, 2023 at 8:30 a.m. ET
From
Agenus Inc.
Via
GlobeNewswire
Agenus to Present Botensilimab Data in Oral Plenary Session at the Society of Gynecologic Oncology 2023 Annual Meeting on Women’s Cancer
February 28, 2023
From
Agenus Inc.
Via
GlobeNewswire
Agenus to Participate in February Investor Conferences
January 26, 2023
From
Agenus Inc.
Via
GlobeNewswire
Agenus (AGEN) Q3 2022 Earnings Call Transcript
November 08, 2022
AGEN earnings call for the period ending September 30, 2022.
Via
The Motley Fool
VBI Vaccines, Agenus Ink Partnership For Combination Brain Cancer Therapy
October 12, 2022
Via
Benzinga
Agenus Presents Clinical Data Demonstrating Durable Responses For Colorectal Cancer Candidate
January 23, 2023
Via
Benzinga
Agenus Presents Clinical Data Demonstrating Durable Responses of Botensilimab/Balstilimab Combination in Metastatic Microsatellite Stable Colorectal Cancer at ASCO GI
January 23, 2023
From
Agenus Inc.
Via
GlobeNewswire
Agenus to Participate at B Riley Securities’ 2023 Virtual Oncology Conference
January 10, 2023
From
Agenus Inc.
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For December 22, 2022
December 22, 2022
Via
Benzinga
Agenus to Present Botensilimab Data at Late-Breaking Oral Session at ASCO-GI
December 21, 2022
From
Agenus Inc.
Via
GlobeNewswire
7 Hot Stocks to Book Profits In Before 2023
December 19, 2022
With major macroeconomic headwinds appearing on the horizon, it’s time for investors to consider the hot stocks to book profits in.
Via
InvestorPlace
Agenus Data at CTOS 2022 Highlight Durable Clinical Responses of Botensilimab / Balstilimab Combination in Advanced Sarcoma
November 17, 2022
From
Agenus Inc.
Via
GlobeNewswire
Agenus to Participate at 5th Annual Evercore ISI HealthCONx Conference
November 16, 2022
From
Agenus Inc.
Via
GlobeNewswire
Why Infinity Pharmaceuticals Shares Tumbled Around 38%; Here Are 79 Biggest Movers From Yesterday
November 15, 2022
Gainers Opiant Pharmaceuticals, Inc. (NASDAQ: OPNT) shares surged 113.8% to settle at $20.10 on Monday. Indivior PLC agreed to acquire Opiant Pharmaceuticals for $20.00 per share in cash, plus...
Via
Benzinga
Miniso Group, Monday.com And Other Big Gainers From Monday
November 15, 2022
U.S. stocks closed lower on Monday, with the Dow Jones dropping more than 200 points. Here is the list of some big stocks recording gains in the previous session.
Via
Benzinga
Why Opiant Pharmaceuticals Shares Are Trading Higher By 115%? Here Are 53 Stocks Moving In Monday's Mid-Day Session
November 14, 2022
Gainers Freight Technologies, Inc. (NASDAQ: FRGT) shares surged 137% to $0.4901 after analysts at Chardan Capital initiated coverage of the stock with a $2.25 price target.
Via
Benzinga
Agenus Data at SITC 2022 Highlight Durable Responses of Botensilimab / Balstilimab Combination in Nine Different Treatment-Resistant Cancers
November 14, 2022
From
Agenus Inc.
Via
GlobeNewswire
360 DigiTech, HUTCHMED And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
November 14, 2022
U.S. stock futures traded lower this morning. Here are some big stocks recording gains in today’s pre-market trading session.
Via
Benzinga
Agenus Provides Corporate Update and Third Quarter 2022 Financial Report
November 08, 2022
From
Agenus Inc.
Via
GlobeNewswire
10 Best Medical Stocks Under $5
October 29, 2022
The medical industry is one of the most lucrative sectors globally, and it is one that sees the highest spending in terms of research and development, and breakthrough advances through keeping up the...
Via
Talk Markets
Agenus to Provide Corporate Update and Third Quarter 2022 Financial Report
October 25, 2022
From
Agenus Inc.
Via
GlobeNewswire
GSK’s older adult RSV vaccine candidate, containing Agenus’ QS-21 STIMULON™, shows 94.1% reduction in severe RSV disease and overall vaccine efficacy of 82.6% in pivotal trial
October 13, 2022
From
Agenus Inc.
Via
GlobeNewswire
VBI Vaccines and Agenus Announce Collaboration to Evaluate VBI-1901 in Combination with Anti-PD-1 Balstilimab in a Phase 2 Study in Primary Glioblastoma Patients
October 12, 2022
From
Agenus Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
October 10, 2022
Gainers Reshape Lifesciences (NASDAQ:RSLS) shares increased by 12.7% to $0.34 during Monday's after-market session. The market value of their outstanding shares is at $1.2 million.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.